CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo.
Oh-Hohenhorst SJ, Tilki D, Ahlers AK, Suling A, Hahn O, Tennstedt P, Matuszcak C, Maar H, Labitzky V, Hanika S, Starzonek S, Baumgart S, Johnsen SA, Kluth M, Sirma H, Simon R, Sauter G, Huland H, Schumacher U, Lange T.
Oh-Hohenhorst SJ, et al. Among authors: matuszcak c.
Cancer Gene Ther. 2022 Jan;29(1):49-61. doi: 10.1038/s41417-020-00288-z. Epub 2021 Jan 7.
Cancer Gene Ther. 2022.
PMID: 33414516
Free PMC article.